The short answer is no — for most healthy people, ginkgo biloba will not meaningfully improve memory. The largest and longest clinical trial ever conducted on the supplement, the Ginkgo Evaluation of Memory study published in JAMA in 2008, followed 3,072 older adults over roughly six years and found that 240 mg per day of standardized ginkgo extract did absolutely nothing to prevent dementia or slow cognitive decline compared to placebo. The National Center for Complementary and Integrative Health has since stated plainly that there is “no conclusive evidence” ginkgo prevents or slows dementia or cognitive decline in healthy individuals. If you are a cognitively normal adult hoping a daily ginkgo capsule will sharpen your thinking, the research does not support that expectation.
The picture gets slightly more complicated, however, for people who already have mild cognitive impairment or early-stage dementia. A smaller but consistent body of evidence suggests that a specific standardized extract — EGb 761 at 240 mg per day, taken for at least 24 weeks — may modestly stabilize cognition and reduce neuropsychiatric symptoms like agitation and anxiety in that population. The effects are real but small, and a 2026 meta-analysis ultimately described the cognitive benefits as “clinically meaningless” in magnitude. This article walks through the landmark trials, the more recent findings from 2025 and 2026, the specific conditions under which ginkgo might help, and what you should realistically consider before spending money on this supplement.
Table of Contents
- What Does the Largest Clinical Trial Say About Ginkgo Biloba and Memory?
- Where Research Suggests Ginkgo May Have Limited Benefits
- What Recent 2025 and 2026 Studies Reveal About Ginkgo and Cognition
- Why Dosage and Extract Type Matter More Than You Think
- Safety Concerns and Drug Interactions Worth Knowing
- How Ginkgo Compares to Other Approaches for Cognitive Health
- What Comes Next for Ginkgo Research
- Conclusion
- Frequently Asked Questions
What Does the Largest Clinical Trial Say About Ginkgo Biloba and Memory?
The GEM study remains the definitive word on ginkgo biloba for dementia prevention. Conducted across four U.S. academic medical centers between 2000 and 2008, it enrolled 3,072 adults aged 72 to 96, randomly assigning them to receive either 240 mg per day of the standardized EGb 761 ginkgo extract or a matching placebo. Over the study period, 523 participants developed dementia — 277 in the ginkgo group and 246 in the placebo group. That slight numerical disadvantage for ginkgo was not statistically significant, but it certainly was not the protective effect supplement manufacturers had hoped for.
A follow-up analysis of the GEM data examined whether ginkgo might at least slow the rate of cognitive decline short of full dementia. It found no difference in any cognitive domain — not memory, not attention, not processing speed, not executive function. The results were consistent regardless of age, sex, or baseline cognitive status. For context, this was not a small pilot study with questionable methodology. It was a federally funded, double-blind, placebo-controlled trial with six years of follow-up, and it produced unambiguous results. When the NCCIH updated its guidance on dietary supplements and cognitive function, the GEM findings were central to its conclusion that ginkgo has no proven role in preventing cognitive decline.
Where Research Suggests Ginkgo May Have Limited Benefits
While the evidence against ginkgo as a preventive supplement is strong, the story is different for people who are already experiencing cognitive problems. A 2015 meta-analysis pooling data from 2,561 participants across multiple randomized controlled trials found that EGb 761 at 240 mg per day could stabilize or slow decline in cognition, daily functioning, and behavioral symptoms over 22 to 26 weeks in patients with existing mild cognitive impairment or dementia. The benefit was most pronounced in patients who also had neuropsychiatric symptoms — things like agitation, depression, and anxiety that often accompany dementia. A 2019 review published in Frontiers in Pharmacology largely confirmed this pattern.
Looking across randomized trials, the authors concluded that EGb 761 may improve cognitive function in patients with mild dementia during long-term use of more than 24 weeks at 240 mg per day. However — and this is the critical caveat — the same review found no consistent benefit in healthy people. If you do not already have a diagnosable cognitive impairment, the research does not support the claim that ginkgo will sharpen your memory or protect you from future decline. This distinction between treatment and prevention is one that supplement marketing almost always blurs, and it matters enormously when you are deciding whether to spend money on a product that can cost $20 to $40 per month for a quality formulation.
What Recent 2025 and 2026 Studies Reveal About Ginkgo and Cognition
The research has not stood still since the GEM trial, and the most recent findings present a mixed but largely sobering picture. A 2025 study published in Frontiers in Neurology examined ginkgo biloba monotherapy in patients with amyloid PET-positive mild cognitive impairment — meaning these individuals had confirmed amyloid plaque buildup in their brains, the hallmark pathology of Alzheimer’s disease. In that specific population, ginkgo was associated with preserved cognition, improved daily functioning, and reduced plasma amyloid-beta oligomerization. That sounds promising, but it is important to note this was a targeted study in a well-defined patient group, not a broad endorsement for general use.
On the other side of the ledger, a 2026 meta-analysis published in ScienceDirect took a comprehensive look at the accumulated evidence and concluded that ginkgo biloba extract produced “small and clinically meaningless effects” on cognition, behavior, and functional ability. The researchers rated the overall evidence quality as low to moderate. Separately, a 2026 randomized controlled trial published in Frontiers in Pharmacology tested a combination of Cistanche tubulosa and ginkgo biloba in 117 healthy adults aged 30 to 65 over 30 days and found enhanced memory linked to cortico-cerebellar reorganization. However, this was a combination product studied for only 30 days, making it difficult to attribute any benefit specifically to ginkgo or to know whether the effect would persist over meaningful time periods.
Why Dosage and Extract Type Matter More Than You Think
One consistent thread across the research is that not all ginkgo supplements are created equal. The benefits that have been observed — modest as they are — are tied almost exclusively to a specific standardized extract called EGb 761, dosed at 240 mg per day. This extract is manufactured under pharmaceutical-grade standards and contains defined concentrations of the active compounds, primarily flavonoid glycosides and terpene lactones. The cheap ginkgo capsules you find at a gas station or discount retailer may contain wildly different amounts of these compounds, or different ratios, or contaminants that dilute whatever effect the active ingredients might have.
Studies using lower doses or non-standardized extracts have generally shown weaker or no effects. This is a common problem with supplement research broadly — consumers assume that if ginkgo works in a clinical trial, the bottle they grabbed off the shelf will deliver the same result. It usually will not. Ginkgo biloba has no FDA-approved medical use and is regulated only as a dietary supplement, which means manufacturers are not required to prove their product matches what was tested in clinical trials. If someone with diagnosed mild cognitive impairment wanted to discuss ginkgo with their physician, the conversation should be specifically about EGb 761 at 240 mg per day for at least 24 weeks, not about a generic ginkgo product at an arbitrary dose.
Safety Concerns and Drug Interactions Worth Knowing
Ginkgo biloba is generally well tolerated in clinical trials, but it is not without risks — particularly for older adults who are the most likely to use it. Ginkgo has antiplatelet properties, meaning it can thin the blood. For people taking anticoagulants like warfarin, antiplatelet drugs like aspirin or clopidogrel, or even common over-the-counter NSAIDs like ibuprofen, adding ginkgo increases the risk of bleeding.
There have been case reports of spontaneous bleeding events, including subdural hematomas, in patients combining ginkgo with blood-thinning medications. Other reported side effects include headache, gastrointestinal upset, dizziness, and allergic skin reactions. People with seizure disorders should exercise particular caution, as ginkgo seeds — sometimes found in poorly manufactured supplements — contain a compound called ginkgotoxin that can lower the seizure threshold. The GEM study itself did not find a significantly elevated rate of serious adverse events in the ginkgo group, which is reassuring, but any supplement that affects platelet function and is being taken by people in their 70s and 80s who are on multiple medications deserves careful consideration, not casual self-prescribing.
How Ginkgo Compares to Other Approaches for Cognitive Health
When you stack ginkgo biloba against lifestyle interventions for cognitive health, the supplement comes up short. Regular aerobic exercise has a substantially stronger evidence base for preserving cognitive function in aging adults. The FINGER trial in Finland demonstrated that a combination of exercise, diet, cognitive training, and vascular risk management meaningfully slowed cognitive decline in at-risk older adults — an effect size that dwarfs anything ginkgo has produced in any trial.
Sleep quality, social engagement, and management of cardiovascular risk factors like hypertension and diabetes also have far more robust evidence supporting their role in brain health. This does not mean ginkgo is worthless in every context, but it does mean that anyone spending $30 a month on ginkgo while remaining sedentary, sleeping poorly, and ignoring their blood pressure is optimizing in the wrong direction. For caregivers considering ginkgo for a loved one with mild cognitive impairment or early dementia, it may be worth a conversation with a neurologist, but it should sit well below exercise, medication adherence, and structured daily routines on the priority list.
What Comes Next for Ginkgo Research
The future of ginkgo biloba research is likely to focus on narrower, better-defined patient populations rather than broad prevention trials. The 2025 study using amyloid PET imaging to select patients represents a more targeted approach — testing whether ginkgo helps a specific biological subgroup rather than everyone over a certain age. This kind of precision is overdue. It is possible that ginkgo does have meaningful effects in people with particular biomarker profiles, even if those effects wash out in large heterogeneous populations.
There is also growing interest in combination therapies, as the 2026 Cistanche-ginkgo trial illustrated. Whether pairing ginkgo with other botanical or pharmaceutical agents might produce synergistic effects is an open question. But given the 2026 meta-analysis verdict of “small and clinically meaningless effects” for ginkgo alone, the burden of proof for any new claim remains high. For now, the honest answer remains unsatisfying but clear: ginkgo biloba is not a proven memory enhancer for healthy people, and its benefits for those with existing cognitive impairment are real but modest at best.
Conclusion
The accumulated evidence on ginkgo biloba and memory tells a consistent story. For cognitively healthy adults, no reliable evidence supports the claim that ginkgo biloba supplements will improve memory, sharpen thinking, or prevent future cognitive decline. The GEM study — the largest and longest trial on this question — found no benefit whatsoever over six years of use.
For people already living with mild cognitive impairment or dementia, standardized EGb 761 extract at 240 mg per day for 24 or more weeks may modestly stabilize cognition and reduce neuropsychiatric symptoms, but even these effects were described as small and of limited clinical significance in the most recent 2026 meta-analysis. If you or a family member are considering ginkgo biloba, the most important step is an honest conversation with a physician who can weigh the supplement against the full picture — current medications, bleeding risk, existing diagnoses, and whether the modest potential benefit justifies the cost and the risk of drug interactions. Do not rely on supplement marketing claims that cherry-pick positive findings while ignoring the weight of negative evidence. And do not let ginkgo distract from the interventions that genuinely matter for brain health: regular physical activity, quality sleep, social connection, cardiovascular risk management, and consistent medical follow-up.
Frequently Asked Questions
Is ginkgo biloba FDA approved for memory or dementia?
No. Ginkgo biloba has no FDA-approved medical use. It is sold only as a dietary supplement, which means manufacturers are not required to demonstrate efficacy before putting it on store shelves. The FDA does not evaluate supplement claims for accuracy the way it evaluates pharmaceutical drugs.
What is EGb 761 and why does it matter?
EGb 761 is a specific standardized extract of ginkgo biloba manufactured under pharmaceutical-grade quality controls. Nearly all of the positive findings in clinical research have used this particular extract at 240 mg per day. Generic or unstandardized ginkgo supplements may not contain the same concentrations of active compounds, making it impossible to assume they will produce similar results.
Can ginkgo biloba interact with blood thinners?
Yes. Ginkgo has antiplatelet effects and can increase bleeding risk when combined with anticoagulants like warfarin, antiplatelet drugs like aspirin or clopidogrel, and NSAIDs like ibuprofen. Anyone on blood-thinning medication should consult their physician before taking ginkgo.
How long do you need to take ginkgo to see any benefit?
The studies that showed modest benefit in patients with existing mild cognitive impairment or dementia used treatment periods of at least 22 to 26 weeks — roughly five to six months. Shorter durations have generally not shown meaningful cognitive improvements, and benefits appear limited to the standardized EGb 761 extract at 240 mg per day.
Should a healthy person take ginkgo biloba to prevent memory loss?
Based on current evidence, no. The GEM study followed over 3,000 healthy older adults for six years and found no preventive benefit. The NCCIH explicitly states there is no conclusive evidence that ginkgo prevents or slows cognitive decline in healthy individuals. Your money and effort are better directed toward regular exercise, sleep hygiene, and cardiovascular health management.
